E7-Targeted Nanotherapeutics for Key HPV Afflicted Cervical Lesions by Employing CRISPR/Cas9 and Poly (Beta-Amino Ester)
Jinfeng Xiong,1,* Songwei Tan,2,* Long Yu,3 Hui Shen,1 Shen Qu,4 Chong Zhang,2 Ci Ren,1 Da Zhu,1 Hui Wang1 1Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 2Tongji Scho...
Guardado en:
Autores principales: | Xiong J, Tan S, Yu L, Shen H, Qu S, Zhang C, Ren C, Zhu D, Wang H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/45dd707cbc884ccf863a440623f1705f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A New HPV score System Predicts the Survival of Patients With Cervical Cancers
por: Qunchao Hu, et al.
Publicado: (2021) -
Exploring the roles of HPV16 variants in head and neck squamous cell carcinoma: current challenges and opportunities
por: Daniela Cochicho, et al.
Publicado: (2021) -
Suspension of proactive recommendations for HPV vaccination has led to a significant increase in HPV infection rates in young Japanese women: real-world data
por: Masayuki Sekine, et al.
Publicado: (2021) -
A case of HPV-53-related cervical cancer in an elderly patient
por: Lieveld M, et al.
Publicado: (2014) -
HPV and Recurrent Respiratory Papillomatosis: A Brief Review
por: Amr Mohamed Ouda, et al.
Publicado: (2021)